The effects of pulmonary rehabilitation in patients with non-cystic fibrosis bronchiectasis: protocol for a randomised controlled trial

Annemarie L Lee, Nola Cecins, Catherine J Hill, Anne E Holland, Linda Rautela, Robert G Stirling, Phillip J Thompson, Christine F McDonald, Sue Jenkins, Annemarie L Lee, Nola Cecins, Catherine J Hill, Anne E Holland, Linda Rautela, Robert G Stirling, Phillip J Thompson, Christine F McDonald, Sue Jenkins

Abstract

Background: Non-cystic fibrosis bronchiectasis is characterised by sputum production, exercise limitation and recurrent infections. Although pulmonary rehabilitation is advocated for this patient group, its effects are unclear. The aims of this study are to determine the short and long term effects of pulmonary rehabilitation on exercise capacity, cough, quality of life and the incidence of acute pulmonary exacerbations.

Methods/design: This randomised controlled trial aims to recruit 64 patients with bronchiectasis from three tertiary institutions. Participants will be randomly allocated to the intervention group (supervised, twice weekly exercise training with regular review of airway clearance therapy) or a control group (twice weekly telephone support). Measurements will be taken at baseline, immediately following the intervention and at six and 12 months following the intervention period by a blinded assessor. Exercise capacity will be measured using the incremental shuttle walk test and the six-minute walk test. Quality of life and health status will be measured using the Chronic Respiratory Questionnaire, Leicester Cough Questionnaire, Assessment of Quality of Life Questionnaire and the Hospital Anxiety and Depression Scale. The rate of hospitalisation will be captured as well as the incidence of acute pulmonary exacerbations using a daily symptom diary.

Discussion: Results from this study will help to determine the efficacy of supervised twice-weekly pulmonary rehabilitation upon exercise capacity and quality of life in patients with bronchiectasis and will contribute to clinical practice guidelines for physiotherapists in the management of this population.

Trial registration: This study protocol is registered with ClinicalTrials.gov (NCT00885521).

Figures

Figure 1
Figure 1
Flow of patients through the study.

References

    1. Tsang KW, Bilton D. Clinical challenges in managing bronchiectasis. Respirology. 2009;14:637–650. doi: 10.1111/j.1440-1843.2009.01569.x.
    1. Wilson C, Jones P, O'Leary CJ, Cole P, Wilson R. Validation of the St George's Respiratory Questionnaire in Bronchiectasis. Am J Respir Crit Care Med. 1997;156:536–541.
    1. Martinez-Garcia MA, Perpina-Tordera M, Roman-Sanchez P, Soler-Cataluna JJ. Quality-of-life determinants in patients with clinically stable bronchiectasis. Chest. 2005;128(2):739–745. doi: 10.1378/chest.128.2.739.
    1. King P, Holdsworth SR, Freezer NJ, Villanueva E, Holmes PW. Characterisation of the onset and presenting clinical features of adult bronchiectasis. Respir Med. 2006;100(12):2183–2189. doi: 10.1016/j.rmed.2006.03.012.
    1. Koulouris N, Retsou S, Kosmas E, Dimakou K, Malagari K, Mantzikopoulos G, Koutsoukou A, Milic-Emili J, Jordanoglou J. Tidal expiratory flow limitation, dyspnoea and exercise capacity in patients with bilateral bronchiectasis. Eur Respir J. 2003;21:743–748. doi: 10.1183/09031936.03.00301103.
    1. O'Leary C, Wilson C, Hansell D, Cole P, Wilson R, Jones P. Relationship between psychological well-being and lung health status in patients with bronchiectasis. Respir Med. 2002;96(9):686–692. doi: 10.1053/rmed.2002.1330.
    1. Chang A, Bilton D. Exacerbations of cystic fibrosis: 4 Non-cystic fibrosis bronchiectasis. Thorax. 2008;63:269–276. doi: 10.1136/thx.2006.060913.
    1. King P, Holdsworth SR, Freezer NJ, Villanueva E, Gallagher M, Holmes PW. Outcome in adult bronchiectasis. COPD. 2005;2:27–34. doi: 10.1081/COPD-200050685.
    1. Australian Institute of Health and Welfare. Chronic respiratory diseases in Australia: Their prevalence, consequences and prevention. Australian Institute of Health and Welfare, Canberra; 2005.
    1. Weycker D, Edelsberg J, Oster G, Tino G. Prevalence and economic burden of bronchiectasis. Clin Pulm Med. 2005;12(4):205–209. doi: 10.1097/01.cpm.0000171422.98696.ed.
    1. Martinez-Garcia MA, Soler-Cataluna JJ, Perpina-Tordera M, Roman-Sanchez P, Soriano J. Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis. Chest. 2007;132:1565–1572. doi: 10.1378/chest.07-0490.
    1. Nici L, Donner CF, Wouters EF, Zuwallack R, Ambrosino N, Bourbeau J, Carone M, Celli B, Engelen M, Fahy B, Garvey C, Goldstein R, Gosselink R, Lareau S, MacIntyre N, Maltais F, Morgan M, O'Donnell D, Prefault C, Reardon J, Rochester C, Schols A, Singh S, Troosters T. on behalf of the ATS/ERS Pulmonary Rehabilitation Writing Committee. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med. 2006;173:1390–1413. doi: 10.1164/rccm.200508-1211ST.
    1. Ries AL, Bauldoff GS, Carlin BW, Casaburi R, Emery CF, Mahler DA, Make B, Rochester CL, ZuWallack R, Herrerias C. Pulmonary rehabilitation. Joint AACP/AACVPR evidence-based clinical practice guidelines. Chest. 2007;131:4S–42S. doi: 10.1378/chest.06-2418.
    1. Griffiths T, Phillips CJ, Davies S, Burr ML, Campbell IA. Cost effectiveness of an outpatient multidisciplinary pulmonary rehabilitation programme. Thorax. 2001;56(10):779–784. doi: 10.1136/thorax.56.10.779.
    1. Guell R, Casan P, Belda J, Sangenis M, Morante F, Guyatt GH, Sanchis J. Long-term effects of outpatient rehabilitation of COPD. A randomized trial. Chest. 2000;117:976–983. doi: 10.1378/chest.117.4.976.
    1. Cecins N, Geelhoed E, Jenkins S. Reduction in hospitalisation following pulmonary rehabilitation in patients with COPD. Aust Health Rev. 2008;22(3):415–422.
    1. Bradley J, Moran F, Greenstone M. Physical training for bronchiectasis (review) The Cochrane Database of Systematic Reviews. 2005. p. CD002166. DOI: 10.1002/14651858.CD002166.
    1. Newall C, Stockley RA, Hill SL. Exercise training and inspiratory muscle training in patients with bronchiectasis. Thorax. 2005;60(11):943–948. doi: 10.1136/thx.2004.028928.
    1. Australian Lung Foundation and Australian Physiotherapy Association. Pulmonary rehabilitation toolkit. 2. 2009.
    1. Mahler D, Wells C. Evaluation of clinical methods for rating dyspnoea. Chest. 1988;93:580–586. doi: 10.1378/chest.93.3.580.
    1. Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD): Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. 2007.
    1. Global Initiative for Asthma (GINA): Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma (GINA) 2007.
    1. Moher M, Schultz K, Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet. 2001;357(4):1191–1194. doi: 10.1016/S0140-6736(00)04337-3.
    1. Australian Lung Foundation. Bronchiectasis. 2009.
    1. Pryor J, Webber BA, Bethune D, Enright S, Howarth A, Potter HM, Tagg L. In: Physiotherapy for cardiac and respiratory conditions. 3. Pryor JA, Prasad SA, editor. Churchill-Livingstone; 2008. Physiotherapy techniques; pp. 161–242.
    1. Holland AE, Hill CJ, Conron M, Munro P, McDonald CF. Short-term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease. Thorax. 2008;63:549–554. doi: 10.1136/thx.2007.088070.
    1. Hill K, Jenkins S, Cecins NM, Philippe D, Hillman D, Eastwood P. Estimating maximum work rate during incremental cycle ergometry testing from six-minute walk distance in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil. 2008;89:1782–1787. doi: 10.1016/j.apmr.2008.01.020.
    1. Borg G. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14:377–381.
    1. Singh S, Morgan M, Scott S. Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax. 1992;47:1019–1024. doi: 10.1136/thx.47.12.1019.
    1. Turner S, Eastwood P, Cecins N, Hillman D, Jenkins S. Physiologic responses to incremental and self-paced exercise in COPD. Chest. 2004;126:766–773. doi: 10.1378/chest.126.3.766.
    1. Williams J, Singh S, Sweell L, Guyatt G, Morgan M. Development of a self-reported Chronic Respiratory Questionnaire (CRQ-SR) Thorax. 2001;56:954–959. doi: 10.1136/thorax.56.12.954.
    1. Schunemann HJ, Goldstein R, Mador MJ, McKim D, Stahl E, Puhan M, Griffith L, Grant B, Austin P, Collins R, Guyatt GH. A randomised trial to evaluate the self-administered standardised chronic respiratory questionnaire. Eur Respir J. 2005;25:31–40. doi: 10.1183/09031936.04.00029704.
    1. Williams J, Singh S, Sewell L, Morgan M. Health status measurement: sensitivity of the self-reported Chronic Respiratory Disease Questionnaire (CRQ-SR) in pulmonary rehabilitation. Thorax. 2003;58:515–518. doi: 10.1136/thorax.58.6.515.
    1. Birring S, Prudon B, Carr A, Singh S, Morgan M, Pavord I. Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ) Thorax. 2003;58:399–343. doi: 10.1136/thorax.58.5.399.
    1. Murray M, Turnbull K, MacQuarrie S, Pentland J, Hill A. Validation of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis. Eur Respir J. 2009;34:125–131. doi: 10.1183/09031936.00160508.
    1. American Thoracic Society. ATS Statement: Guidelines for the Six-Minute-Walk Test. Am J Respir Crit Care Med. 2002;166:111–117.
    1. Snaith RP. The Hospital Anxiety and Depression Scale. Health Qual Life Outcomes. 2003;1:29. doi: 10.1186/1477-7525-1-29.
    1. Coventry PA. Does pulmonary rehabilitation reduce anxiety and depression in chronic obstructive pulmonary disease? Curr Opin Pulm Med. 2009;15(2):143–149. doi: 10.1097/MCP.0b013e3283218318.
    1. Hawthorne G, Osborne R. Population norms and meaningful differences for the Assessment of Quality of Life (AQoL) measure. Aust N Z J Public Health. 2005;29(2):136–142. doi: 10.1111/j.1467-842X.2005.tb00063.x.
    1. Miller M, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, Grinten C van der, Gustafsson C, Jensen R, Johnson D, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J. Standardisation of spirometry. Eur Respir J. 2005;26:319–338. doi: 10.1183/09031936.05.00034805.
    1. Lee AL, Button BM, Ellis S, Stirling R, Wilson JW, Holland AE, Denehy L. Clinical determinants of the 6-minute walk test in bronchiectasis. Respir Med. 2009;103:780–785. doi: 10.1016/j.rmed.2008.11.005.
    1. Loebinger MR, Wells AU, Hansell DM, Chinyanganya N, Devaraj A, Meister M, Wilson R. Mortality in bronchiectasis: a long-term study assessing the factors influencing survival. Eur Respir J. 2009;34:843–849. doi: 10.1183/09031936.00003709.
    1. Lee AL, Button BM, Denehy L. Current Australian and New Zealand physiotherapy practice in the management of patients with bronchiectasis and chronic obstructive pulmonary disease. N Z J Physio. 2008;36(2):49–58.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere